Clostridioides difficile

Associated infections

• Antibiotic-associated diarrhoea
• C. difficile infection (colitis)
• Pseudomembranous colitis
• Toxic megacolon and colonic perforation
• Ileus and paralytic presentations without diarrhoea
• Recurrent C. difficile infection
• Sepsis secondary to severe fulminant colitis

Transmission route

Transmission is faecal-oral. Spores shed by symptomatic and colonised patients contaminate the immediate patient environment, commodes, bedpans, bedding, bed rails, floors and shared equipment, and are carried to other patients on the hands of staff. Shedding continues after diarrhoea resolves, and asymptomatic carriers contribute a substantial proportion of onward transmission that is invisible to symptom-based control measures. Antimicrobial exposure is the dominant risk factor because it disrupts the protective colonic microbiota, removing the metabolic competition and secondary bile acid production that normally suppress germination and outgrowth; advanced age, prolonged hospitalisation, gastrointestinal surgery and severe comorbidity are additional risks.

Persistent reservoirs have been demonstrated in hospital wastewater infrastructure, including sink traps, toilets, showers and ward wastewater, which are not addressed by routine surface disinfection programmes. Toilet flushing generates aerosols capable of dispersing spores over a distance, and hand-wash basin traps have been implicated as reservoirs for a range of organisms in outbreak investigations. These are wastewater and drainage phenomena, distinct from the potable and purified water supply, and the distinction matters when a facility is deciding what to investigate.

Hands are the principal vector between reservoir and patient. Alcohol-based hand rub does not inactivate spores, so hand washing with soap and water, which removes them mechanically, is required after contact with a patient known or suspected to have C. difficile infection. Gloves, gowns, single-patient equipment, prompt isolation and sporicidal environmental cleaning form the remainder of the control set. Because spores survive on dry surfaces for long periods, terminal cleaning of a vacated room with a sporicidal agent is a defined and auditable step rather than an optional one.

Relevance in endoscopy and reprocessing

C. difficile is not a recognised waterborne organism in the endoscope reprocessing context and has not been implicated as a contaminant of purified water systems or automated endoscope reprocessor circuits. Purified water systems are aerobic, oligotrophic and continuously flowing; the vegetative organism cannot survive there and the spore, while durable, does not multiply and has no mechanism to colonise or amplify within the treatment train. The organism is not a contributor to premise-plumbing biofilm in the way that Pseudomonas species and non-tuberculous mycobacteria are.

Its relevance to endoscopy is instead a device and process concern. Colonoscopes and flexible sigmoidoscopes contact colonic content that may contain very large numbers of spores, and the endoscope reprocessing cycle is a high-level disinfection process, not a sterilisation process. Standard high-level disinfectants are not reliably sporicidal at the contact times and concentrations used in routine automated cycles, so the spore is not fully addressed by the disinfection step. Thorough mechanical cleaning is therefore the primary defence: bedside pre-cleaning, prompt transport, correct manual brushing of every channel, and flushing to physically remove faecal material and the spores within it. Where the log reduction achieved by cleaning is inadequate, spores can in principle survive a complete cycle.

Despite this theoretical pathway, endoscopy-transmitted C. difficile infection is not a prominent feature of the transmission literature, which is dominated by Gram-negative organisms associated with duodenoscope elevator mechanisms and by mycobacteria associated with reprocessing water. The practical implications are nonetheless clear. Facilities should ensure that colonoscopes used on patients with known or suspected infection receive scrupulous cleaning, that reprocessing room workflow prevents contact between soiled transport containers and clean areas, that sinks and drains within the reprocessing room are managed as potential reservoirs and are not sited where they can splash onto clean instruments or into open sample vessels, and that reusable transport trays and containers are subject to sporicidal cleaning. In CSD, instruments returning from colorectal procedures pass through washer-disinfectors and, where applicable, steam sterilisation, which is sporicidal and closes the gap that exists in flexible endoscope processing.

Interpreting a detection

Detection of C. difficile in an endoscope reprocessing final rinse or supply water sample is an atypical and operationally significant result, and it should not be interpreted as a water treatment failure. The organism is not expected in that matrix at all, and it will not be recovered by the heterotrophic plate count and membrane filtration methods used in routine surveillance, since those are aerobic incubations on non-selective media. A positive result therefore implies that a specific anaerobic or selective method, or a molecular assay, was applied, and the first question is why. Confirm what was tested, by what method, and on whose request.

The next step is to establish the plausibility of the result before acting on it. Confirm the identification independently, since other anaerobic and aerobic spore-forming Gram-positive bacilli can be misassigned, and confirm the provenance of the sample, including whether it was processed in a laboratory that concurrently handles faecal specimens or C. difficile cultures, where cross-contamination is a realistic explanation. Verify sample labelling and chain of custody. If the result stands, the search should be for a faecal contamination pathway rather than a treatment plant deficiency: inadequate manual cleaning and channel brushing before disinfection, drain or waste backflow into the reprocessor, splashing from a nearby sink or drain into an open sample vessel, a contaminated sampling port, or contamination of the sample during collection by a person who had recent contact with soiled instruments.

A single confirmed isolate warrants immediate escalation to the infection prevention team and quarantine of the affected reprocessor pending investigation, because the finding indicates a breach of separation between soiled and clean pathways rather than a marginal water-quality drift. Repeat sampling should be performed under controlled and observed conditions and, if the reprocessor is implicated, should include the water inlet, the internal circuit and a processed endoscope channel sample so that the point of entry can be localised. Records to review include manual cleaning competency and audit results, reprocessor self-disinfection and drain-back function, plumbing changes or backflow prevention device status, and any recent works affecting drainage in the reprocessing room. A recurring or multi-sample pattern should trigger suspension of scope release from the affected unit, a look-back review of instruments processed since the last clear result, and consideration of engineering assessment of the reprocessor's waste and fill pathways.

Antimicrobial resistance

The clinically important resistance property of C. difficile is not antimicrobial resistance in the conventional sense but the physical resilience of the spore. The spore coat and exosporium withstand desiccation, alcohol-based hand rub, quaternary ammonium compounds and many general-purpose hospital disinfectants, and germination requires no more than the bile salt environment of the small bowel. Environmental decontamination therefore requires sporicidal chemistry, most commonly chlorine-releasing compounds at a validated concentration and contact time, or hydrogen peroxide vapour for terminal room decontamination, applied after thorough physical cleaning since organic soil neutralises chlorine. Sub-lethal exposure to some disinfectants has been reported to affect sporulation behaviour, which is a further argument for using agents at validated concentrations rather than diluted or expired preparations.

Regarding therapy, reduced susceptibility to metronidazole has been reported and guidelines have moved away from it as first-line treatment in favour of oral vancomycin and fidaxomicin, with fidaxomicin favoured in several settings for lower recurrence rates attributed to its narrower spectrum and lesser disruption of the residual microbiota. Faecal microbiota transplantation and monoclonal antibody therapy directed at toxin B are established options for recurrent disease. Reduced susceptibility to vancomycin and to fidaxomicin has been described but remains uncommon.

Resistance to fluoroquinolones, clindamycin, cephalosporins and other broad-spectrum agents is relevant in a different way, as a driver of infection rather than a barrier to treatment. Such resistance allows epidemic lineages to expand under antimicrobial selection pressure, and the international spread of fluoroquinolone-resistant lineages illustrates the effect directly. Antimicrobial stewardship is therefore a core element of C. difficile control alongside environmental measures, hand hygiene with soap and water, and isolation. In the reprocessing context the operative conclusion is simple: no antimicrobial consideration applies, and the only property that matters is that the spore is not reliably inactivated by routine high-level disinfection, which places the burden of control on mechanical cleaning and on maintaining separation between soiled and clean pathways.